With box warnings

Without box warnings

Branded

Generic

3 results

exjade
(deferasirox)
Novartis Pharmaceuticals Corporation
Usage: Exjade is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
ferriprox
(deferiprone)
Chiesi USA, Inc.
Usage: FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for myelodysplastic syndrome or Diamond Blackfan anemia.
jadenu
(deferasirox)
Novartis Pharmaceuticals Corporation
Usage: JADENU is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia in patients aged 10 and older with specific liver iron concentration and serum ferritin levels.

Iron Chelator class drugs

exjade